Each year in the U.S., 1 in 120 babies is born with heart disease. Many others are diagnosed during childhood and adolescence. All told, there are millions of children living with serious heart diseases.
Researchers at Children’s Hospital of Philadelphia (CHOP) and many other pediatric cardiac centers are making great progress in revolutionizing treatments and improving outcomes for these children, but more funding is needed to accelerate their work.
Exceptional Patient Care and Treatment
The Cardiac Center at CHOP is one of the world’s largest and most accomplished pediatric heart centers, offering care for children with acquired and congenital heart conditions from around the globe. We perform a high volume of cardiothoracic surgeries — including 600 open heart procedures a year — and have some of the best patient outcomes in the world.
Researchers and clinicians at CHOP are working every day to improve the lifelong health and well-being of children with congenital heart disease. Our team is conducting research on the genetic roots of CDH, new methods of treating single ventricle defects, inventing new diagnostic tools and treatment options of patients with lymphatic flow disorders, and much more.
Patient Ambassadors for Philly Spin-In have a big job to do. It’s up to them to represent the millions of children living with heart disease each year. As they share their stories, they help the world understand what congenital heart disease takes away and why it’s worth supporting institutions like Children’s Hospital of Philadelphia.
“We have in recent years made incredible important breakthroughs that nobody else has had in some of the most important issues affecting our patients. We really need the support of philanthropy to make that possible.”
— Matthew Gillespie, MD, Interventional Cardiologist